The study found no mean difference in all-cause healthcare costs for patients with newly diagnosed nonvalvular atrial fibrillation initiating treatment with dabigatran versus warfarin.
John C. White, DPM, MS
Advertisement
Articles by John C. White, DPM, MS
Advertisement
Latest Updated Articles
- Predictors of Healthcare Costs After Initiating Dabigatran Versus Warfarin
Published: February 2nd 2018 | Updated:
Advertisement
Advertisement